EFFECT OF GINSENG ON CISPLATIN-INDUCED EMESIS
EFFECT OF GINSENG ON CISPLATIN-INDUCED EMESIS
批准号:
7033894
负责人:
CHUN-SU YUAN
金额:
$22.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2008-03-31
关键词:
alternative medicineantiemeticsantioxidantsapoptosiscisplatindisease /disorder modeldrug adverse effectdrug interactionsdrug screening /evaluationemesishigh performance liquid chromatographylaboratory ratmedicinal plantsneoplasm /cancer chemotherapypharmacokineticsplant extractsstatistics /biometrystomach emptyingtissue /cell culture
中文摘要
描述(由申请方提供):使用顺铂等止血药物治疗癌症会产生严重的不良反应,不仅会恶化患者的生活质量,还会导致患者拒绝潜在的治愈性化疗。恶心/呕吐是化疗药物的一个显着不良反应,应充分控制以降低发病率并提高化疗的有效性。目前可用的止吐药物缓解了症状,特别是当联合使用时,但可能导致额外的药物相关不良事件和药物相互作用。顺铂诱导的胃排空延迟也可能导致恶心/呕吐的发病机制。引起胃肠道病变的精液事件可能是由氧化剂损伤肠道时释放的神经递质引起的。因此,我们建议使用一种草药抗氧化剂,西洋参,拮抗氧化事件,并确定其在治疗顺铂引起的呕吐的潜力。我们将研究西洋参根提取物(AGRE)和西洋参浆果提取物(AGBE)及其活性成分(人参皂苷Rg 1,Rb 1,Re和Rd)在减少化疗引起的恶心/呕吐和改善大鼠模型胃排空方面的作用。大鼠对顺铂等催吐刺激的反应是改变饮食习惯,表现为增加消耗非营养物质,如高岭土(一种粘土),称为异食癖。顺铂诱导高岭土消耗的显著增加,并且该大鼠模型已被用于评价新型止吐化合物。此外,顺铂还延迟大鼠的胃排空。我们假设,AGRE,AGBE及其活性成分的管理将有效地减少异食癖,改善胃排空,同时保留顺铂的杀肿瘤活性。在拟议的研究中,我们将评估AGRE,AGBE和人参皂苷Rg 1,Rb 1,Re和Rd在顺铂治疗的大鼠中的止吐活性,并确定中药对顺铂的杀肿瘤活性的影响。由于人参在其他组织中显示出杀肿瘤特性和抗氧化保护作用,我们预计西洋参将成为癌症化疗中有效的止吐治疗。
英文摘要
DESCRIPTION (provided by applicant): Treatment of cancer with hemotherapeutic agents such as cisplatin is associated with severe adverse effects that not only worsen patients' quality of life but also could lead to their refusal of potentially curative chemotherapy. Nausea/vomiting, a significant adverse effect of chemotherapeutic drugs, should be adequately controlled to reduce morbidity and improve effectiveness of chemotherapy. The currently available anti-emetic drugs relieve the symptoms especially when used in combinations, but lead to the possibility of additional drug-related adverse events and drug-drug interactions. Cisplatin-induced delayed gastric emptying could also contribute to the pathogenesis of nausea/vomiting. The seminal event that causes the gastrointestinal pathology is likely caused by neurotransmitters released during oxidant injury to the gut. We therefore propose to use an herbal anti-oxidant, American ginseng, to antagonize the oxidant events and to determine it's potential in treating cisplatin-induced emesis. We will investigate the role of American ginseng root extract (AGRE) and American ginseng berry extract (AGBE), and their active constituents (ginsenosides Rg1, Rb1, Re, and Rd ), in reducing chemotherapy-induced nausea/vomiting and in improving gastric emptying in a rat model. Rats react to emetic stimuli, like cisplatin, by altered feeding habits, manifested as increased consumption of non-nutritive substances like kaolin (a type of clay), known as pica. Cisplatin induces a significant increase in kaolin consumption, and this rat model has been utilized to evaluate novel anti-emetic compounds. In addition, cisplatin also delays gastric emptying in rats. We hypothesize that administration of AGRE, AGBE and their active constituents will effectively reduce pica and improve gastric emptying, while preserving the tumoricidal activity of cisplatin. In the proposed study, we will evaluate anti-emetic activities of AGRE, AGBE and ginsenosides Rg1, Rb1, Re, and Rd in rats treated with cisplatin, and determine herbal effects on the tumoricidal activity of cisplatin. Due to the fact that ginseng has shown tumoricidal properties and antioxidant protection from chemotherapeutic agents in other tissues, we expect that American ginseng will be an efficacious anti-emetic treatment in cancer chemotherapy.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/ptr.2383
发表时间:
2009-01
期刊:
PHYTOTHERAPY RESEARCH
影响因子:
7.2
作者:
[Wang, Chong-Zhi, Xie, Jing-Tian, Fishbein, Anna, Aung, Han H., He, Hui, Mehendale, Sangeeta R., He, Tong-Chuan, Du, Wei, Yuan, Chun-Su]
通讯作者:
Yuan, Chun-Su
Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells.
灵芝提取物抑制 SW 480 人结直肠癌细胞的增殖。
DOI:
--
发表时间:
2006
期刊:
Experimental oncology
影响因子:
--
作者:
[Xie,JT, Wang,CZ, Wicks,S, Yin,JJ, Kong,J, Li,J, Li,YC, Yuan,CS]
通讯作者:
Yuan,CS
DOI:
--
发表时间:
2007-09
期刊:
Experimental oncology
影响因子:
--
作者:
[H. Aung;Chong-Zhi Wang;M. Ni;A. Fishbein;S. Mehendale;Jing-tian Xie;C. Y. Shoyama;C. Yuan]
通讯作者:
H. Aung;Chong-Zhi Wang;M. Ni;A. Fishbein;S. Mehendale;Jing-tian Xie;C. Y. Shoyama;C. Yuan
DOI:
10.3892/ijo.32.5.975
发表时间:
2008-05
期刊:
International journal of oncology
影响因子:
5.2
作者:
[Xiaoji Luo;Chong-Zhi Wang;Jin Chen;Wen-Xin Song;Jinyong Luo;Ni Tang;Bai-Cheng He;Q. Kang;Yitao Wang;W. Du;T. He;C. Yuan]
通讯作者:
Xiaoji Luo;Chong-Zhi Wang;Jin Chen;Wen-Xin Song;Jinyong Luo;Ni Tang;Bai-Cheng He;Q. Kang;Yitao Wang;W. Du;T. He;C. Yuan
DOI:
10.3892/ijo.31.5.1149
发表时间:
2007-11
期刊:
International journal of oncology
影响因子:
5.2
作者:
[Chong-Zhi Wang;Jing-tian Xie;Bin Zhang;M. Ni;A. Fishbein;H. Aung;S. Mehendale;W. Du;T. He;C. Yuan]
通讯作者:
Chong-Zhi Wang;Jing-tian Xie;Bin Zhang;M. Ni;A. Fishbein;H. Aung;S. Mehendale;W. Du;T. He;C. Yuan
共 6 条
Center for Herbal Research on Colorectal Cancer
-
批准号:7910395
-
项目类别:
-
资助金额:$118.8万
-
财政年份:2008
-
负责人:CHUN-SU YUAN
-
依托单位:
Center for Herbal Research on Colorectal Cancer
-
批准号:8299547
-
项目类别:
-
资助金额:$115.26万
-
财政年份:2008
-
负责人:CHUN-SU YUAN
-
依托单位:
Center for Herbal Research on Colorectal Cancer
-
批准号:7691352
-
项目类别:
-
资助金额:$120.0万
-
财政年份:2008
-
负责人:CHUN-SU YUAN
-
依托单位:
Center for Herbal Research on Colorectal Cancer
-
批准号:8121645
-
项目类别:
-
资助金额:$117.61万
-
财政年份:2008
-
负责人:CHUN-SU YUAN
-
依托单位:
SAFETY OF GANODERMA LUCIDUM EXTRACT
-
批准号:7604792
-
项目类别:
-
资助金额:$2.7万
-
财政年份:2007
-
负责人:CHUN-SU YUAN
-
依托单位:
Herbal Effects on Oxidant Dynamics in Cardiomyocytes
-
批准号:7415231
-
项目类别:
-
资助金额:$22.56万
-
财政年份:2007
-
负责人:CHUN-SU YUAN
-
依托单位:
Herbal Effects on Oxidant Dynamics in Cardiomyocytes
-
批准号:7256174
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2007
-
负责人:CHUN-SU YUAN
-
依托单位:
SAFETY OF GANODERMA LUCIDUM EXTRACT
-
批准号:7378654
-
项目类别:
-
资助金额:$0.28万
-
财政年份:2006
-
负责人:CHUN-SU YUAN
-
依托单位:
MULTIPLE-DOSED METHYLNALTREXONE IN VOLUNTEERS
-
批准号:7201008
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2005
-
负责人:CHUN-SU YUAN
-
依托单位:
EFFECT OF GINSENG ON CISPLATIN-INDUCED EMESIS
-
批准号:6923326
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2005
-
负责人:CHUN-SU YUAN
-
依托单位:
CARDIOPROTECTIVE EFFECTS OF AMERICAN GINSENG
-
批准号:6875699
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2004
-
负责人:CHUN-SU YUAN
-
依托单位:
Phase II Study of Methylnaltrexone in Cancer Pts.
-
批准号:7040697
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2004
-
负责人:CHUN-SU YUAN
-
依托单位:
CARDIOPROTECTIVE EFFECTS OF AMERICAN GINSENG
-
批准号:6768052
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2004
-
负责人:CHUN-SU YUAN
-
依托单位:
R21 Project: Anti-diabetic Effects of Panax ginseng
-
批准号:6624244
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2002
-
负责人:CHUN-SU YUAN
-
依托单位:
R21 Project: Anti-diabetic Effects of Panax ginseng
-
批准号:6473207
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2002
-
负责人:CHUN-SU YUAN
-
依托单位:
Cardiovascular Effects of Scutellaria baicelensis
-
批准号:6534556
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2001
-
负责人:CHUN-SU YUAN
-
依托单位:
Cardiovascular Effects of Scutellaria baicelensis
-
批准号:6433903
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2001
-
负责人:CHUN-SU YUAN
-
依托单位:
IMPROVING OF CARE BY REVERSAL OF OPIOID CONSTIPATION
-
批准号:6350319
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2000
-
负责人:CHUN-SU YUAN
-
依托单位:
IMPROVING OF CARE BY REVERSAL OF OPIOID CONSTIPATION
-
批准号:6045395
-
项目类别:
-
资助金额:$22.99万
-
财政年份:2000
-
负责人:CHUN-SU YUAN
-
依托单位:
IMPROVING OF CARE BY REVERSAL OF OPIOID CONSTIPATION
-
批准号:6497500
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2000
-
负责人:CHUN-SU YUAN
-
依托单位:
海外基金